Status:
COMPLETED
Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 1.
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Asthma Patients
Healthy Subjects
Eligibility:
All Genders
6-65 years
Brief Summary
The main objectives of the study are 1. to study the different T cell subtypes (Th1, Th2, Th17 and Treg) in the lower airways of healthy subjects and clinically different asthma patients, based on a ...
Eligibility Criteria
Inclusion
- asthma diagnosis
Exclusion
- viral/bacterial/fungal infection with fever (\<1 month )
- other airway diseases (CF, ciliar dyskinesia, bronchiectasis)
- asthma exacerbation (\<3 months)
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
395 Patients enrolled
Trial Details
Trial ID
NCT01224938
Start Date
October 1 2010
End Date
September 1 2013
Last Update
July 16 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Leuven
Leuven, Vlaams-Brabant, Belgium, 3000